NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 68 filers reported holding NOVELION THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | 0.0% | 1,046 | -17.6% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 1,270 | -4.5% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 1,330 | +43.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 930 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 930 | -3.1% | 0.00% | – |
| Q2 2018 | $3,000 | -25.0% | 960 | -24.4% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 1,270 | +8.5% | 0.00% | – |
| Q4 2017 | $4,000 | -63.6% | 1,170 | -22.3% | 0.00% | – |
| Q3 2017 | $11,000 | -47.6% | 1,505 | -30.9% | 0.00% | – |
| Q2 2017 | $21,000 | +90.9% | 2,177 | +116.4% | 0.00% | – |
| Q1 2017 | $11,000 | +10.0% | 1,006 | 0.0% | 0.00% | – |
| Q4 2016 | $10,000 | – | 1,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 831,440 | $8,930,000 | 15.27% |
| Stonepine Capital Management, LLC | 1,560,487 | $16,760,000 | 9.44% |
| Sarissa Capital Management LP | 1,025,000 | $11,008,000 | 4.35% |
| ARMISTICE CAPITAL, LLC | 1,852,000 | $19,890,000 | 4.11% |
| Opaleye Management Inc. | 730,000 | $7,840,000 | 3.90% |
| Broadfin Capital, LLC | 1,948,554 | $20,927,000 | 2.54% |
| Tiger Legatus Capital Management, LLC | 447,852 | $4,810,000 | 2.10% |
| JW Asset Management, LLC | 310,299 | $3,333,000 | 0.69% |
| Kingstown Capital | 599,998 | $6,444,000 | 0.67% |
| KNOTT DAVID M | 109,184 | $1,173,000 | 0.56% |